期刊
EMERGING INFECTIOUS DISEASES
卷 14, 期 11, 页码 1689-1692出版社
CENTERS DISEASE CONTROL
DOI: 10.3201/eid1411.080431
关键词
-
资金
- NIH National Institute of Allergy and Infectious Diseases [U54 AI065357]
- Wellcome Trust
Genetic research into the select agents Burkholderia pseudomallei and B. mallei is currently hampered by a paucity of approved antimicrobial drug-selection markers. The strict regulations imposed on researchers in the United States but not in other parts of the world lead to discrepancies in practice, hinder distribution of genetically modified strains, and impede progress in the field. Deliberation and decisions regarding alternative selection markers (antimicrobial and nonantimicrobial drugs) by the international community, regulatory authorities, and funding agencies are needed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据